144 related articles for article (PubMed ID: 29093570)
1. Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Zhang Y; Li D; Feng F; An L; Hui F; Dang D; Zhao Q
Sci Rep; 2017 Nov; 7(1):14809. PubMed ID: 29093570
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.
Ma L; Dong P; Liu L; Gao Q; Duan M; Zhang S; Chen S; Xue R; Wang X
Biochem Biophys Res Commun; 2016 Apr; 473(2):503-10. PubMed ID: 27003260
[TBL] [Abstract][Full Text] [Related]
4. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
[TBL] [Abstract][Full Text] [Related]
6. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
7. Expression of NOTCH receptors and ligands and prognosis of hepatocellular carcinoma.
Zhao B; Hu S; Xiao Q; Fan S; Yu X; Li C; Dong P; Zheng J
Biomark Med; 2020 Dec; 14(17):1631-1639. PubMed ID: 33336594
[No Abstract] [Full Text] [Related]
8. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
[TBL] [Abstract][Full Text] [Related]
9. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
10. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
11. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
Luo J; Wang P; Wang R; Wang J; Liu M; Xiong S; Li Y; Cheng B
Oncotarget; 2016 Feb; 7(8):9525-37. PubMed ID: 26848615
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of Notch3 predicts poor survival for hepatocellular carcinomas.
Hu L; Xue F; Shao M; Deng A; Wei G
Biosci Trends; 2013 Jun; 7(3):152-6. PubMed ID: 23836039
[TBL] [Abstract][Full Text] [Related]
14. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma.
Zhang HF; Li W; Han YD
Cancer Biomark; 2018 Feb; 21(3):575-582. PubMed ID: 29278875
[TBL] [Abstract][Full Text] [Related]
15. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Dong L; Ni J; Hu W; Yu C; Li H
Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
[TBL] [Abstract][Full Text] [Related]
19. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis.
Wu T; Jiao M; Jing L; Wang MC; Sun HF; Li Q; Bai YY; Wei YC; Nan KJ; Guo H
Onco Targets Ther; 2015; 8():3105-14. PubMed ID: 26543379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]